Vitamin d test showdown: which lab method is best?
NCT ID NCT07337499
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see how well a new lab method (Maglumi X3 SNIBE) measures vitamin D levels compared to other standard methods. Researchers will take blood samples from 200 healthy volunteers and patients. The goal is to ensure different labs give consistent and accurate results for vitamin D tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Two hundred subjects will be recruited, including healthy individuals who are employees of the Galeazzi-Sant'Ambrogio Hospital, as well as patients at the time of pre-admission or admission who are referred for major orthopedic surgery (hip and knee replacement) or for cardiothoracic surgery.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy volunteer subjects: Subjects who sign the informed consent to participate in the study Age ≥ 18 years Employees, in various roles, of the IRCCS Galeazzi-Sant'Ambrogio Hospital -Patients: Subjects who sign the informed consent to participate in the study Age ≥ 18 years Patients referred for major orthopedic surgery: hip and knee replacement (bicompartmental and unicompartmental) Patients referred for cardiothoracic surgery Exclusion Criteria: * Neoplastic diseases (until remission) * Grade I, II, and III obesity * Age \< 18 years * Women who are pregnant or breastfeeding, based on self-declaration * Individuals unable to understand and make decisions
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Quantification of 25-(OH)D in physiological condition are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Laboratory of Experimental Biochemistry and Advanced Diagnostic
RECRUITINGMilan, Milano, 20175, Italy